Over 100 patients in tumor reduction study

International trials have shown that a triple-acting therapeutic injection can effectively reduce or eliminate cancer tumors. The injection was administered to over 100 patients with head, neck, and lung cancers, leading to tumor reduction in more than one-third of them, with noticeable changes appearing within weeks, and complete tumor removal achieved in 15 cases. The new medication delivers unprecedented results for those resistant to chemotherapy and immunotherapy. It is administered as a subcutaneous injection once every three weeks, with mild to moderate side effects.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article